Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

An Early Prospective Study of the Traq™ Device for Characterization of Binocular Ocular Function in Normal Subjects and Subjects With Recent Traumatic Brain Injury

Rebiscan, Inc. · NCT07742878

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 12+ · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
10
US sites recruiting
1
Study start
July 14, 2026
Record last updated
August 3, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The early prospective study of Traq™ (an investigational binocular ophthalmic neurodiagnostic device) will measure binocular ocular functions (bilateral foveal fixation, foveal binocularity, and fovea-tracked saccadic latency) in normal subjects and those with history of mild-to moderate traumatic brain injury (mTBI).

Being studied: Binocular ophthalmic neurodiagnostic device

Conditions: Mild Traumatic Brain Injury, Concussion; Binocular Visual Function; Neuro-Ophthalmology; Saccadic Eye Movements

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Age 12 years or older at the time of enrollment.
  • Able to understand and sign an informed consent form (or with parent/guardian for subjects less than 18 years of age).
  • Willing and able to complete all required study visits and test assessments.
  • Subjects with no history of traumatic brain injury (normal arm).
  • Subjects with a history of mild to moderate traumatic brain injury (mTBI) within the last six months, (post-TBI arm).

Exclusion Criteria

  • Concurrent participation in another drug or device clinical investigation.
  • Subject with a history of eye disease which could reduce, or limit reflected polarized light from the retina, such as corneal scarring, cataract, glaucoma, degenerative retinal conditions (e.g., age-related macular degeneration, diabetic retinopathy), or other conditions which may decrease device signal reflectance.
  • Subjects who are pregnant, planning to become pregnant, or are breastfeeding.

Recruiting US locations

  • Elite Eye Care/Elite Vision Therapy

    Waukee, IA 50263

    Site contact: Heidi Bell, OD · 515-987-3937 · heidibellod@gmail.com

Study contacts (from the official record)

  • Justin Shaka · 857-600-0982 · jgshaka@rebiscan.com
All neurology studies in Iowa →
An Early Prospective Study of the Traq™ Device for… (NCT07742878) | Bored Studies